PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30057316-6	2018	Consistent with the increases in GLUT1 and ABCG2 mRNAs, protein expression of GLUT1 and BCRP was increased by pioglitazone.	Pioglitazone	110-122	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	88-92	
30057316-5	2018	In addition, pioglitazone increased HIF-1 target genes such as the mRNAs of glucose transporter 1 (GLUT1) and breast cancer resistance protein (BCRP/ABCG2), in a concentration-dependent manner.	Pioglitazone	13-25	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	110-142	
30057316-5	2018	In addition, pioglitazone increased HIF-1 target genes such as the mRNAs of glucose transporter 1 (GLUT1) and breast cancer resistance protein (BCRP/ABCG2), in a concentration-dependent manner.	Pioglitazone	13-25	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	144-148	
30057316-5	2018	In addition, pioglitazone increased HIF-1 target genes such as the mRNAs of glucose transporter 1 (GLUT1) and breast cancer resistance protein (BCRP/ABCG2), in a concentration-dependent manner.	Pioglitazone	13-25	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	149-154	
30057316-7	2018	In addition, GLUT inhibitor phloretin-sensitive D-[3H]glucose uptake activity and BCRP inhibitor Ko143-sensitive accumulation of Hoecsht33342, a BCRP substrate, were significantly enhanced by treatment with pioglitazone.	Pioglitazone	207-219	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	82-86	
30057316-7	2018	In addition, GLUT inhibitor phloretin-sensitive D-[3H]glucose uptake activity and BCRP inhibitor Ko143-sensitive accumulation of Hoecsht33342, a BCRP substrate, were significantly enhanced by treatment with pioglitazone.	Pioglitazone	207-219	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	145-149